Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Torrent Pharmaceuticals Ltd.

Torrent Pharma

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
18 05 2021 Audited Results & Final Dividend Inter alia, the Board would also consider the following: i. Payment of Final Dividend for the year 2020-21. ii. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If approved by the Board of Directors, the said item will be placed for Shareholders approval in the ensuing Annual General Meetin
27 07 2021 Quarterly Results
26 10 2021 Quarterly Results
25 01 2022 Quarterly Results & Interim Dividend
25 05 2022 Final Dividend & Bonus issue & Audited Results
29 07 2022 Quarterly Results
21 10 2022 Quarterly Results
25 01 2023 Quarterly Results & Interim Dividend
30 05 2023 Final Dividend & Audited Results
07 08 2023 Quarterly Results
23 10 2023 Quarterly Results
02 02 2024 Quarterly Results & Interim Dividend
25 10 2024 Quarterly Results
24 01 2025 Quarterly Results & Interim Dividend
20 05 2025 Final Dividend & Audited Results
28 07 2025 Quarterly Results & Inter alia, will also consider the Issue of Unsecured or Secured Redeemable Non Convertible Debentures or Bonds by way of private placement.

News

03-FEB-2024

Torrent Pharmaceuticals reports 52% rise in Q3 consolidated net profit

Total consolidated income of the company increased by 8.79% at Rs 2699 crore for Q3FY24

02:36 PM
04-JUL-2025

Torrent Pharma executes SPA to acquire 2.41% stake in J.B. Chemicals & Pharmaceuticals

The company has executed share purchase agreement with employees of the J.B. Chemicals & Pharmaceuticals

10:40 AM
05-DEC-2024

Torrent Pharma enters into agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands

Torrent has been marketing these brands since 2022 as part of an existing co-marketing agreement with Boehringer Ingelheim India

11:12 AM
05-JAN-2024

Torrent Pharmaceuticals incorporates Wholly Owned Subsidiary in Colombia

Torrent Colombia is incorporated with the object of providing business support to the Company in the relevant jurisdiction

09:01 AM
06-MAR-2024

USFDA issues EIR to Torrent Pharmaceuticals’ Gujarat facility

USFDA has now successfully concluded inspection at Torrent Pharmaceuticals’ Oral-Oncology manufacturing facility

10:13 AM
10-NOV-2022

Torrent Pharmaceuticals raises Rs 500 crore through NCDs

Date of maturity of said NCDs will be 7 years from date of allotment

11:00 AM
10-NOV-2023

Torrent Pharmaceuticals enters into licensing and supply agreement with Zydus Lifesciences

With a once daily, 4mg dose regimen, Saroglitazar Mg enables better compliance, reduces pill burden and offers greater convenience for patients

03:27 PM
12-DEC-2023

USFDA concludes pre-approval inspection at Torrent Pharmaceuticals’ Gujarat facility

At the end of the inspection, the Company was issued a Form 483 with 5 procedural observations

09:23 AM
14-DEC-2022

Torrent Pharmaceuticals enters into partnership with Boehringer Ingelheim India

Empagliflozin is a novel sodium glucose co-transporter-2 inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus

04:00 PM
14-FEB-2023

Torrent Pharmaceuticals forays into OTC segment with calcium supplement brand

The calcium is sourced from natural ingredients like oyster shell, having good absorption/bioavailability in the body

02:29 PM
16-JUN-2023

Torrent Pharmaceuticals gets EIR for Gujarat Oral-Oncology manufacturing facility

The inspection has now been successfully closed by the USFDA

11:51 AM
18-JUL-2025

Torrent Pharmaceuticals seeks CCI’s nod to acquire majority stake in J B Chemicals

After the completion of the deal, Torrent Pharmaceuticals will become India’s second most valued pharma company

02:12 PM
20-MAR-2023

USFDA concludes pre-approval inspection at Torrent Pharmaceuticals’ Gujarat facility

At the end of the inspection, the company has been issued a ‘Form 483’ with 1 observation, which is procedural in nature

11:50 AM
21-JUN-2025

Torrent Pharmaceuticals raises Rs 200 crore through Commercial Papers

Tenure of the instrument is 90 days

11:35 AM
21-SEP-2024

Torrent Pharmaceuticals raises Rs 200 crore through Commercial Papers

The company has issued CPs at interest rate of 7.32% per annum

02:27 PM
24-AUG-2023

Torrent Pharmaceuticals gets EIR for Dahej manufacturing facility

Earlier, USFDA had conducted inspection at the said manufacturing facility from May 17, 2023 to May 25, 2023

09:44 AM
25-OCT-2023

Torrent Pharmaceuticals reports 24% rise in Q2 consolidated net profit

Total consolidated income of the company increased by 16.43% at Rs 2,686 crore for Q2FY24

12:42 PM
26-AUG-2022

ICRA upgrades Torrent Pharma’s long term credit rating to ‘AA+/Stable’

ICRA has reaffirmed its rating on commercial paper programme at ‘Al+’

11:19 AM
27-DEC-2024

Torrent Pharmaceuticals raises Rs 200 crore through commercial papers

Maturity of the said Commercial Papers will be on March 26, 2025

02:10 PM
27-JAN-2023

Torrent Pharmaceuticals reports 14% rise in Q3 consolidated net profit

Total consolidated income of the company increased by 15.07% to Rs 2481 crore for Q3FY23

12:50 PM
27-JUN-2025

Torrent Pharmaceuticals raises Rs 300 crore through Commercial Papers

Maturity of the said Commercial Papers will be on September 26, 2025

11:30 AM
27-MAY-2022

Torrent Pharma enters into agreement with Dr Reddy’s Laboratories

The complete integration and transition of the brands are expected to be completed by June 2022

09:37 AM
27-SEP-2022

Torrent Pharmaceuticals inks pacts to acquire 100% stake in Curatio

The transaction is subject to conditions precedent and is expected to close within one month’s time

04:25 PM
27-SEP-2024

Torrent Pharmaceuticals incorporates Wholly owned subsidiary in Chile

Torrent Pharma Chile is incorporated with the object of providing business support to the company in the relevant jurisdiction

09:47 AM
28-JUL-2025

Torrent Pharmaceuticals reports 20% rise in Q1 consolidated net profit

The total consolidated income of the company increased by 8.95% at Rs 3,141 crore for Q1FY26

04:59 PM
29-SEP-2022

USFDA concludes inspection at Torrent Pharmaceuticals’ Gujarat manufacturing facility

The USFDA inspected facility from September 19, 2022 to September 28, 2022

09:28 AM
30-JUN-2025

Torrent Pharmaceuticals to acquire controlling stake in JB Pharma

The company will acquire 46.39% equity stake of JB Pharma through a SPA at a consideration of Rs 11,917 crore

09:28 AM
Enrich money logo